Please enable JavaScript.
Coggle requires JavaScript to display documents.
L5 Systematic Review2 :princess::skin-tone-3: âSTEPS to Systematic reviewâ
L5
Systematic Review2
:princess::skin-tone-3:
â
STEPS
to Systematic reviewâ
ðŪ Step 1 - Formulate the
question
Question components
:
PICO
:tada:
:Problem/Patients, Interventions, Comparison intervention, Outcomes
Types
of question āđāļāđāļ§āļāļāļāļīāļāļąāļāļī
: question abt ........
Etiology/Harm
most common!
Prognosis
Diagnostic test
(paper āđāļāļĩāđāļĒāļ§āļāļĩāđ āđāļāđāļ screening)
Therapy or Prevention
Health economics
ðŪ Step 2 : Put tgt a team/ Plan a review
âProposing & registering review titlesâ
Decide on ur topic for a review
(NOT duplicate any work alrd published or register with The Cochrane Collaboration)
Search The Cochrane Library for any published protocols & review
Advantages
of Systematic reviews
ðŪ Step 3 : Write a
protocol
(protocol = blueprint in research)
Why have a protocol?
What goes into a protocol?
:frame_with_picture:
Background
Length ~ 1-1.5 pages
Show reason why review&study this, Explain the importance of problem (clinical q), āļāđāļēāļāļāļīāļāđāļŦāļĨāđāļāļāđāļāļĄāļđāļĨ
Description of condition
â short description abt important problem (eg. Info abt ds, Dx, prognosis, economic importance<include prevalence or incidence>)
Description of intervention
(should compare âĨ 2 things)
How the intervention might work
(mechanism of action)
Why itâs important to do this review?
:pen:
Objective
Should be
one sentence
noting
Main objective
of study
(āđāļĄāđāļāđāļāļāļĄāļĩāļŦāļĨāļēāļĒāļāđāļ*)
Should note Interventions, Suffered fr health problems population & outcomes
Should cover other objective āļĢāļāļāļāļ·āđāļāđ
Clinical outcomes** should cover both Benefit parts & Harmful parts
Eg. Study effeciency & Adverse effects of drug A in treating pt with suicidal risk
:koala:
Methods of the review
Criteria for considering studies
for this review
Types of studies
â RCTs, Quasi-RCT, etc
(Quasi main objective is
no bias
)
Types of participants
Ds or Conditions of interest should be defined using Explicit criteria
Board population & Setting of interest should be defined
Inclusion criteria
Exclusion criteria
Types of interventions
Intervention vs Placebo
Intervention A vs Int. B or Int. C
Dose, Freq, Duration, Mode of administration
Types of Outcome measures
Primary
outcome
Should normally :!: reflect âĨ 1 potential benefit & âĨ 1 potential area of harm
Should be as
few
as possible
(as many will need to prove a lot -> inc. sample size)
Secondary
outcomes
(non-primary outcomes)
Eg. Mortality rate, Relapse rate, Success rate, Quality of life issues, Adverse events, Cost-effectiveness
Search methods for identification of studies
Electronic searches
Bibliographic databases searched
Dates & Period searched
Any constraints eg language
Searching other resources
Unpublished literature
Grey literature sources such as internal report, conferences proceedings
Etc
Data collection & analysis
:pineapple:
Selection of studies
Studies (not reports) as Unit of interest
Identifying multiple reports fr the same study
A typical process of selecting studies
Implementation of selection process
eg āļāļģāđāļĢāļ·āđāļāļ DM āļāđāļāļ§āļĢāļĄāļĩspecialist for DM
Selection âexcluded studiesâ
:!?:
Title & Abstract evaluation form
Title & Abstract not related with Intervention
Not RCT or Quasi-RCT
Not outcomes between Intervention & Comparison
No relevant Health problem
Children or Pregnancy
Studied in Animal only
(if ja try drugs in human, it should hv been test in Animal first)
:pineapple:
Data extraction & Mx
Extract data fr published reports (use data collection form)
Data are
extracted independently by > 1 author
should be stated + how disagreement are solved
If relevant, methods for processing data in preparation for analysis should be described
:pineapple:
Quality assessment in included studies
:star::star:
Bias
:pineapple:
Measures of treatment effect
Dichotomous data
(Yes/No question)
Risk ratio (RR)
Odds ratio (OR)
Risk difference (RD)
Continuous data
Difference in means (MD)
Standardized difference in means (SMD)
Time-to-event data
:pineapple:
Dealing with missing data
Strategies for dealing with missing data should be described
Include
missing participants due to drop-out
Whether an Intention-to-treat analysis will be conducted?
:pineapple:Assessment of heterogeneity
:pineapple:
Assessment of reporting bias
Should describe how publication bias & other reporting biases are addressed
:pineapple:
Data synthesis
:pineapple:
Subgroup analysis & Inx of heterogeneity
:pineapple:Sensitivity analysis
References
Additional ref
ðŪ Step 4 : Locate & Select studies
ðŪ Step 5 : Assess studiesâ quality
ðŪ Step 6 : Retrieve data
ðŪ Step 7 : Analayze & Present results
ðŪ Step 8 : Interpret results & Write reviews
Limitations of Systematic reviews specific to health promotion